Table 2.
Laboratory findings at baseline and after 5, 12, and 24 months of administration of anakinra
| M0 | M5 | M12 | M24 | |
|---|---|---|---|---|
| Therapy | PN 37.5 mg daily | Anakinra 100 mg daily | Anakinra 100 mg every 2 days | Anakinra 100 mg every 2 days |
| CRP (mg/L) | 59 | 2.3 | 0.6 | 0.3 |
| IgM (g/L) | 2.75 | 3.02 | 3.2 | 2.88 |
| WBC (*109/L) | 22.900 | 4450 | 6800 | 7100 |
| N (*109/L) | 21.200 | 1600 | 3300 | 3930 |
| Hb (mg/dl) | 9.5 | 11.6 | 13.8 | 13.6 |
M month, PN prednisone, CRP C-reactive protein, IgM immunoglobulin M, WBC white blood cells, N neutrophils, Hb hemoglobin